A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Clinical trial NCT04729621 · COMPLETED

Trial details

NCT number: NCT04729621
Sponsor: Teva Pharmaceuticals USA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal

Start date: 2021-03-22
Primary completion: 2022-12-31
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.